<div dir="ltr">Dear RAISE faculty,<div>in case you missed it, please find below info about an NIH funding opportunity on Bioinformatics and Computational Biology that relates to AI and ML. Let us know if there is interest.</div><div><br></div><div>Deadlines: </div><div>June 5, 2026</div><div>October 5, 2026 <br>4 years, $1M in direct costs</div><div><br></div><div>best,</div><div>Vassilis and Amit</div><div><br></div><div><br><div class="gmail_quote gmail_quote_container"><div dir="ltr" class="gmail_attr">---------- Forwarded message ---------<br>From: <strong class="gmail_sendername" dir="auto">Brandon Reese</strong> <span dir="auto"><<a href="mailto:breese@ucr.edu">breese@ucr.edu</a>></span><br>Date: Fri, Feb 13, 2026 at 2:02 PM<br>Subject: NIH funding opportunity: Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)<br>To: <<a href="mailto:csfaculty@cs.ucr.edu">csfaculty@cs.ucr.edu</a>>, <<a href="mailto:eceprofs@ece.ucr.edu">eceprofs@ece.ucr.edu</a>><br>Cc: Huguette Albrecht <<a href="mailto:huguetta@ucr.edu">huguetta@ucr.edu</a>>, Aimee Anaya <<a href="mailto:aanaya@engr.ucr.edu">aanaya@engr.ucr.edu</a>>, Lucy Matsukawa <<a href="mailto:lmats003@engr.ucr.edu">lmats003@engr.ucr.edu</a>><br></div><br><br><div dir="ltr"><div><div style="font-family:tahoma,sans-serif;font-size:small"><b style="font-family:Calibri,sans-serif;font-size:11pt"><u>NIH: Advancing Bioinformatics, Translational
Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)</u></b></div><div style="font-family:tahoma,sans-serif;font-size:small"><b style="font-family:Calibri,sans-serif;font-size:11pt"><u><br></u></b></div>
<p class="MsoNormal" style="margin:0in 0in 8pt;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif">The National Library of Medicine (NLM) wishes to advance
groundbreaking and innovative research in bioinformatics, translational
bioinformatics and computational biology, which are related areas of biomedical
informatics that aim to understand biological data using storage, analytic and
interpretive methods. This initiative will support NLM's mission to accelerate
discovery by enhancing human health through data-driven research.</p>
<p class="MsoNormal" style="margin:0in 0in 8pt;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif">This funding opportunity aims to address the growing need to
leverage transformative technologies—such as artificial intelligence (AI),
machine learning, and large-scale computational platforms—to extract actionable
knowledge from vast, diverse, and complex biological datasets. By enabling more
effective interpretation and integration of multi-dimensional biological and
biomedical data, this research will ultimately contribute to improving
individual and population health outcomes.</p>
<p class="MsoNormal" style="margin:0in 0in 8pt;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif">For this funding opportunity, areas of bioinformatics and
computational biology for which methodological advances are of interest
include, but are not limited to:</p>
<p style="margin:0in 0in 0in 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>Various types of omics and multi-omics studies,
including genomics, transcriptomics, proteomics, epigenomics, structural or
spatial omics, comparative omics, and multimodal integrations of those.</p>
<p style="margin:0in 0in 0in 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>Microbiome studies, including studies on
host-microbiome interactions.</p>
<p style="margin:0in 0in 0in 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>Metagenomic and/or metaproteomic studies.</p>
<p style="margin:0in 0in 0in 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>Studies that use artificial intelligence (AI)
and machine learning (ML) applications for predictive and analytical
bioinformatics research.</p>
<p style="margin:0in 0in 0in 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>Computational biology method development for
analysis of genomic or non-genomic biological data and related phenomena.</p>
<p style="margin:0in 0in 0in 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>Genetic variation and disease association
studies, including methodological advances for determining combinatorial
variant associations, and for accelerating discovery beyond rare diseases, such
as for chronic diseases.</p>
<p style="margin:0in 0in 0in 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>Phenotypic studies, including methodological
advances for complex trait analyses.</p>
<p style="margin:0in 0in 0in 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>Translational bioinformatic studies that aim to
provide a pathway for effective treatment strategies or have a tangible effect
on health outcomes.</p>
<p style="margin:0in 0in 0in 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>Translational bioinformatic studies applicable
to personalized or genomic medicine.</p>
<p style="margin:0in 0in 0in 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>Pathway and/or regulatory network studies.</p>
<p style="margin:0in 0in 0in 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>Systems biology studies, including analysis and
visualization of large datasets.</p>
<p style="margin:0in 0in 0in 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>Cell-cell interaction informatics, and other
types of cellular/tissue/organism networking studies.</p>
<p style="margin:0in 0in 0in 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>Single cell informatics.</p>
<p style="margin:0in 0in 0in 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>Informatics related to biomarker discovery.</p>
<p style="margin:0in 0in 0in 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>Analysis of drug targets.</p>
<p style="margin:0in 0in 8pt 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>Various emerging or other informatics studies on
biological data, including but not limited to multimodal studies that encompass
multiple data types and/or research domains, or studies relevant to
bioinformatic data harmonization, integration <span class="gmail_default" style="font-family:tahoma,sans-serif;font-size:small"> </span>and reuse.</p>
<p class="MsoNormal" style="margin:0in 0in 8pt;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif">Example topics of interest include, but are not limited to:</p>
<p style="margin:0in 0in 0in 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>Interdisciplinary approaches that are informed
by functional biological and/or biomedical data.</p>
<p style="margin:0in 0in 0in 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>Approaches that result in whole usable
pipelines, workflows or resources, rather than software products that perform
segmented functions in a larger workflow.</p>
<p style="margin:0in 0in 0in 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>Tools and methods that can be developed,
applied, evaluated and disseminated within the scope of the proposed project,
and which are durable and autonomously updatable.</p>
<p style="margin:0in 0in 0in 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>Tools and workflows that are FAIR (Findable,
Accessible, Interoperable, Reusable) and easily findable by the wide research
community in well-documented, user-friendly, publicly available resources, and
which encompass ethical considerations <span class="gmail_default" style="font-family:tahoma,sans-serif;font-size:small"> </span>for data representation and downstream
use.</p>
<p style="margin:0in 0in 0in 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>Translational bioinformatics approaches that are
broadly adaptable and generalizable.</p>
<p style="margin:0in 0in 0in 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>Non-translational bioinformatics advances that
contribute tangible functional knowledge for downstream use.</p>
<p style="margin:0in 0in 8pt 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>Computational models that are adaptable,
credible, explainable and testable by real-world data.</p>
<p class="MsoNormal" style="margin:0in 0in 8pt;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><b>Budget and Project Period: </b>Up to $250K per year in
direct costs over 4 years<b></b></p>
<p class="MsoNormal" style="margin:0in 0in 8pt;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><b>Submission Deadlines: </b></p>
<p style="margin:0in 0in 0in 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>June 5, 2026</p>
<p style="margin:0in 0in 0in 0.5in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-size-adjust:none;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span>October 5, 2026<b></b></p>
<p class="MsoNormal" style="margin:0in 0in 0in 0.25in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif">**Recurring deadlines in 2027 and 2028</p>
<p class="MsoNormal" style="margin:0in 0in 0in 0.25in;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><b> </b></p>
<p class="MsoNormal" style="margin:0in 0in 8pt;line-height:107%;font-size:11pt;font-family:Calibri,sans-serif"><b>For more information, go to: </b><a href="https://www.grants.gov/search-results-detail/359003" style="color:rgb(5,99,193)" target="_blank">https://www.grants.gov/search-results-detail/359003</a>
</p><br clear="all"></div><div><div dir="ltr" class="gmail_signature" data-smartmail="gmail_signature"><div dir="ltr"><div></div><div><font color="#888888" style="font-family:tahoma,sans-serif"><div dir="ltr"><div dir="ltr"><p class="MsoNormal"><b><span style="font-size:10pt">Brandon Reese</span></b></p>
<p class="MsoNormal"><span style="font-size:10pt">Contract and Grant Facilitator</span></p>
<p class="MsoNormal"><span style="font-size:10pt">Bourns College
of Engineering</span></p>
<p class="MsoNormal"><span style="font-size:10pt">University of
California, Riverside</span></p>
<p class="MsoNormal"><font color="#00b050"><span style="font-size:13.3333px"><b><a href="mailto:breese@ucr.edu" target="_blank">breese@ucr.edu</a></b></span></font></p></div></div></font><span style="font-family:tahoma,sans-serif"><br></span></div>
</div></div></div></div>
</div></div></div>